Articles tagged "Pancreas transplantation"

2022 American Transplant Congress
Normothermic Ex Vivo Pancreas Perfusion for the Preservation of Porcine Pancreas Grafts
C. Parmentier, S. Ray, L. Mazilescu, M. Kawamura, T. Goto, Y. Noguchi, B. Arulratnam, S. Ganesh, M. Selzner, T. Reichman
Multi-Organ Transplant Department, University Health Network - Toronto General Hospital, Toronto, ON, Canada
*Purpose: The purpose of this study was to develop a stable porcine model for normothermic ex-vivo pancreas perfusion (NEVPP) for the preservation of grafts with…
2022 American Transplant Congress
Incidence and Outcomes of CMV Infection in Pancreas Transplant with Thymoglobulin Induction: A Single Center Experience
W. Abusalah, A. Yadav
Thomas Jefferson University Hospital, Philadelphia, PA
*Purpose: CMV infection is a major infectious complication in pancreas transplant recipients (PTR). Incidence of CMV viremia in PTR with thymoglobulin induction and it's effect…
2022 American Transplant Congress
When Pancreata Fly: Excellent Results from Long Distance Imported Pancreas Allografts
N. Owen-Simon, G. Dube, P. Sandoval, L. Ratner, K. McCune
Department of Surgery, Columbia University College of Physicians and Surgeons, New York, NY
*Purpose: To address long waitlist times and increase pancreas transplantation in a competitive donor service area, our center has adopted a protocol for long distance…
2022 American Transplant Congress
Association of Physical Function and Depression Among Kidney-Pancreas Transplant Recipients Using PROMIS CATs
A. Yantsis¹, W. Ghazi¹, A. Norgate¹, M. Sanchez¹, Y. Sun¹, R. Gupta¹, R. Ahuja¹, I. Mucsi²
¹University Health Network, Toronto, ON, Canada, ²Toronto General Hospital, Toronto, ON, Canada
*Purpose: The number of kidney-pancreas (KP) transplants is increasing accounting for approximately 6% of all kidney transplants in Canada. In addition to kidney failure and…
2022 American Transplant Congress
Long-Term Insulin Independence Achieved by a Multimodal Approach to Beta-Cell Replacement in Patients with Type I Diabetes
M. Nunez¹, S. Wisel², J. Gardner³, G. Worner⁴, G. Roll⁵, S. Syed³, G. Szot¹, M. Tavakol¹, K. Johnson¹, A. Posselt⁴, P. Stock⁶
¹Surgery, University of California, San Francisco, San Francisco, CA, ²Cedars-Sinai Medical Center, Los Angeles, CA, ³University of California, San Francisco, San Francisco, CA, ⁴University of California San Francisco, San Francisco, CA, ⁵UCSF Medical Center, San Francisco, CA, ⁶Univ of California-San Francisco, San Francisco, CA
*Purpose: Long-term insulin independence in beta-cell replacement, via islet or pancreas transplant, remains limited by the toxic effects of calcineurin inhibitors (CNI) on beta cells…
2022 American Transplant Congress
Abdominal Gynecologic Procedures Following Pancreas Transplantation: A Single Center Retrospective Analysis
E. Loya¹, J. A. Powelson¹, A. J. Lutz¹, K. Kasper², M. S. Richard¹, J. A. Fridell¹
¹Surgery, Indiana University School of Medicine, Indianapolis, IN, ²Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, IN
*Purpose: The purpose of this study was to review the outcomes of abdominal gynecologic (gyne) procedures in patients who have previously undergone pancreas transplantation (PTx).*Methods:…
2022 American Transplant Congress
Normothermic Ex Vivo Perfusion of Discarded Human Pancreases: A Feasibility Study to Expand the Pancreas Donor Pool
C. Parmentier, S. Ray, L. Mazilescu, M. Kawamura, Y. Noguchi, T. Goto, B. Arulratnam, S. Ganesh, M. Selzner, T. Reichman
UHN - Toronto General Hospital, Toronto, ON, Canada
*Purpose: Normothermic Ex Vivo Perfusion (NEVPP) model has been used in the clinical setting for Lung, heart, liver, and kidney. However, a system for human…
2022 American Transplant Congress
Successful Utilization of Advanced Diabetes Technology to Optimize Glucose Control as a Bridge to Simultaneous Liver and Pancreas Transplantation
M. M. Stumpf¹, S. Lee¹, E. Marriner¹, S. Rao¹, J. Oberholzer², S. Pelletier³
¹University of Virginia, Charlottesville, VA, ²University of Illinois at Chicago, Charlottesville, VA, ³University of Virginia Health System, Charlottesville, VA
*Purpose: We present the case of a 20 year old female with history of autoimmune hepatitis diagnosed in 2014, treated with tacrolimus, and insulin dependent…
2021 American Transplant Congress
Impact of Insulin Therapy in Pancreas Transplantation Donors on Graft Outcomes: An Analysis of the Optn/unos Database
E. Montagud-Marrahi¹, F. Ausania², Y. Fundora², A. Amor³, E. Esmatjes³, J. Ferrer², I. Revuelta¹, D. Cucchiari¹, J. Rovira⁴, M. Musquera⁵, C. Fondevila², F. Diekmann¹, P. Ventura-Aguiar¹
¹Nephrology and Kidney Transplantation Department, Hospital Clinic de Barcelona, Barcelona, Spain, ²Hepatobiliopancreatic and Liver Transplant Department, Hospital Clinic de Barcelona, Barcelona, Spain, ³Endocrinology Department, Hospital Clinic de Barcelona, Barcelona, Spain, ⁴Laboratori Experimental de Nefrologia I Trasplantament (LENIT), CRB CELLEX, Fundació Clínic, IDIBAPS, Hospital Clinic de Barcelona, Barcelona, Spain, ⁵Urology Department, Hospital Clinic de Barcelona, Barcelona, Spain
*Purpose: Hyperglycemia requiring insulin treatment is frequent in critically ill patients and potential pancreas donors. Information on the impact of donor insulin use on pancreas…
2021 American Transplant Congress
Human Leukocyte Antigen Mismatches Between Donor-Recipient or Donor-Donor are Not Associated with Adverse Pancreas Outcomes in Pancreas After Kidney Transplant Recipients
S. Parajuli, D. Kaufman, B. Welch, H. Sollinger, D. Mandelbrot, J. Odorico
University of Wisconsin, MADISON, WI
*Purpose: A greater degree of HLA mismatch has been previously associated with inferior graft survival in kidney and pancreas transplantation. Pancreas after kidney (PAK) recipients…